Corrigendum to "Critical evaluation of cadexomer-iodine ointment and povidone-iodine sugar ointment" [Int. J. Pharm. 372 (2009) 85-90] (DOI:10.1016/j.ijpharm.2009.01.007);Critical evaluation of cadexomer-iodine ointment and povidone-iodine sugar ointment

International Journal of Pharmaceutics

Volumn 372, Issue 1-2, 2009, Pages 85-90

  Noda, Yasuhiro ^a,b   Fujii, Kiori ^a   Fujii, Satoshi ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b KINJO GAKUIN UNIVERSITY   (Japan)

Author keywords

Cadexomer iodine; Povidone iodine; Pressure ulcer; Wound exudates

Indexed keywords

CADEX; CADEXOMER IODINE; OINTMENT BASE; PHOSPHATIDYLCHOLINE; POVIDONE IODINE; SUGAR; TYROSINE; U PASTA; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DECUBITUS; DRUG FORMULATION; DRUG PENETRATION; LIPID MEMBRANE; PRIORITY JOURNAL; WATER ABSORPTION; WOUND FLUID; WOUND HEALING;

EID: 64149088246     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.01.027     Document Type: Erratum

References (18)

1. Balin A.K., and Pratt L. Dilute povidone-iodine solutions inhibit human skin fibroblast growth. Dermatol. Surg. 28 (2002) 210-214
2. Berkelman R.L., Holland B.W., and Anderson R.L. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J. Clin. Microbiol. 15 (1982) 635-639
3. Bianchi J. Cadexomer-iodine in the treatment of venous leg ulcers: what is the evidence?. J. Wound Care 10 (2001) 225-229
4. British Standard Institute Test methods, 2002. Test methods for primary wound dressings. Part 1. Aspects of absorbency, Section 3.4, Fluid affinity of amorphous hydrogel wound dressings. BS EN 13726-1.
5. Khan M.N., and Naqvi A.H. Antiseptics, iodine, povidone iodine and traumatic wound cleansing. J. Tissue Viability 16 (2006) 6-10
6. Knutson R.A., Merbitz L.A., Creekmore M.A., and Snipes H.G. Use of sugar and povidone-iodine to enhance wound healing: five year's experience. South Med. J. 74 (1981) 1329-1335
7. Kawashima Y., Takeuchi H., Hino T., Niwa T., Lin T.L., Sekigawa F., and Kawahara K. Low-substituted hydroxypropylcellulose as a sustained-drug release matrix base or disintegrant depending on its particle size and loading in formulation. Pharm. Res. 10 (1993) 351-355
8. Lamme E.N., Gustafsson T.O., and Middelkoop E. Cadexomer-iodine ointment shows stimulation of epidermal regeneration in experimental full-thickness wounds. Arch. Dermatol. Res. 290 (1998) 18-24
9. Li C.H. Kinetics and mechanism of 2,6-di-iodotyrosine formation. J. Am. Chem. Soc. 64 (1942) 1147-1152
10. Nakao H., Yamazaki M., Tsuboi R., and Ogawa H. Mixture of sugar and povidone-iodine stimulates wound healing by activating keratinocytes and fibroblast functions. Arch. Dermatol. Res. 298 (2006) 175-182
11. Ohtani T., Mizuashi M., Ito Y., and Aiba S. Cadexomer as well as cadexomer iodine induces the production of proinflammatory cytokines and vascular endothelial growth factor by human macrophages. Exp. Dermatol. 16 (2007) 318-323
12. Ohura, T., 2005. Guideline for Local Treatment of Pressure Ulcers (in Japanese), Japanese Society of Pressure Ulcers, Syorinsha, Tokyo.
13. Oliveira A.S., and Santos V.L. Topical iodophor use in chronic wounds: a literature review. Rev. Lat. Am. Enfermagem. 15 (2007) 671-676
14. Rosa U., Pennisi F., Bianchi R., Federighi G., and Donato L. Chemical and biological effects of iodination on human albumin. Biochim. Biophys. Acta 133 (1967) 486-498
15. Takikawa K., Nakano M., and Arita T. Change in apparent permeability of iodine in the presence of polyvinylpyrrolidone. Chem. Pharm. Bull. 26 (1978) 874-879
16. Vlachou M.D., Rekkas D.M., Dallas P.P., and Choulis N.H. Development and in vitro evaluation of griseofulvin gels using Franz diffusion cells. Int. J. Pharm. 82 (1992) 47-52
17. Zanger M., and Rabinowitz J.L. A nuclear magnetic resonance investigation of the iodination of 1,2-disubstituted ethylenes. Evidence for a trans addition-cis elimination. J. Org. Chem. 40 (1975) 248-250
18. Zhou L.H., Nahm W.K., Badiavas E., Yufit T., and Falanga V. Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds. Br. J. Dermatol. 146 (2002) 365-374